Download the app and get the day’s most important stories.

July 27, 2021 | Via BBC

US to Maintain Covid Foreign Travel Restrictions

The US does not intend to lift Covid-19 travel restrictions for non-Americans, the White House has said. The decision comes amid pressure from airlines and tourism industry lobbyists to lift the sweeping ban before the end of the summer travel season. The decision was due to a rise in infections, the Delta variant’s transmissibility and a recent advisory against travel to the UK.

July 27, 2021 | Via Sky News

One Dead and Four People Missing After Blast at German Industrial Park

A body has been recovered but four people remain missing, following an explosion at a German industrial park for chemical companies. The blast in Leverkusen, which has left at least sixteen other people injured, was declared an “extreme threat” by authorities. It is not yet clear what caused the explosion. Residents have been asked to remain inside their homes, keeping doors and windows closed.

July 27, 2021 | Via NBC News

The Two Koreas Restore Communication Channels

The leaders of North and South Korea restored suspended communication channels between them and agreed to improve ties, both governments said Tuesday, amid a two-and-a-half year-stalemate in U.S.-led diplomacy aimed at stripping North Korea of its nuclear weapons. Since April, Kim and South Korean President Moon Jae-in exchanged personal letters several times and decided to normalize the cross-border communication channels.

July 27, 2021 | Via The Guardian

Jeff Bezos Offers Nasa $2bn in Exchange for Moon Mission Contract

Fresh off his trip to space, Jeff Bezos on Monday offered to cover up to $2bn in Nasa costs if the US space agency awards his company Blue Origin a contract to make a spacecraft designed to land astronauts back on the moon. Nasa in April awarded SpaceX, owned by rival billionaire Elon Musk, a $2.9bn contract to build a spacecraft to bring astronauts to the lunar surface as early as 2024.

July 27, 2021 | Via Reuters

FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment

Merck & Co Inc (MRK.N) said on Tuesday that the U.S. Food and Drug Administration approved its immunotherapy Keytruda as a treatment for an early form of a tough-to-treat breast cancer in combination with chemotherapy. The FDA approval is for treating triple-negative breast cancer (TNBC), an aggressive form of the disease with an increased risk of recurrence.

July 2021
« Jun   Aug »